Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

698. To ask the Minister for Health the details of all planning and research work under way on the impact of the result of Brexit negotiations in his Department or related State agencies; if this analysis is intended for publication; the expected completion and publication date respectively of this research, in tabular form; and if he will make a statement on the matter. [46122/17]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

The Department of Foreign Affairs and Trade has responsibility for coordinating the whole-of-Government response to Brexit. The Department of Health is working closely with the Department of Foreign Affairs and Trade to address the many challenges resulting from Brexit. This cooperation also involves the relevant State Agencies.

Work at Cabinet level is being prepared through cross-Departmental coordination structures. These represent a frequent and active channel through which all relevant Departments are providing their research, analysis and overall policy input to the Government’s wider response to Brexit, including its priorities for the ongoing Article 50 negotiations between the EU and the UK.

As the outcome of the negotiations is not yet known, an important focus of the planning and preparation being undertaken through these structures is on deepening the Government’s analysis and understanding of the exact consequences of a range of different possible scenarios. This represents an intensification of efforts to build on the Government’s contingency planning.

The Deputy Secretary, Policy and Strategy Division, and the Assistant Secretary, R and D and Health Analytics Division are the lead officials in the Department of Health for planning and coordination on the negotiations for Brexit. The Department of Health participates fully in the Interdepartmental Group on the EU and Brexit, and its workgroups as appropriate.

The Department of Health and its agencies have been conducting detailed analysis on the impacts of Brexit in the area of health. A number of issues are being examined and contingency planning for a range of eventualities is underway. A key issue will be to ensure that there is minimum disruption to health services and that essential services are maintained on a cross-Border, all-island and Ireland-UK basis. The health sector has a highly mobile workforce and free movement issues and the mutual recognition and assurance of professional qualifications are being considered. On regulatory issues, it is clear that having a single set of rules across the European Union is enormously helpful – to protect human health, to ensure consumer protection and to provide a level playing field for industry. The UK no longer being part of a harmonised regulatory system in relation to food safety standards, pharmaceuticals, medical devices and cosmetics could necessitate increased certification requirements or disrupt trade between Ireland and the UK. Ensuring continuity in the supply of medicines and medical devices following the UK’s departure from the EU is a priority. The issue of customs is of relevance as it relates to additional food safety controls and medicines. The implications of Brexit for networks and organisations such as the EU Rapid Alert System for Food and Feed, the European Reference Networks on rare diseases and the European Centre for Disease Prevention and Control are also under consideration.

These issues are currently being examined by my Department and its agencies and this work will continue over the period ahead. The key priorities for my Department are to ensure continuity in the provision of health services and to avoid, or mitigate changes to the current situation that would have a negative impact on human health. These are also key factors in considering the prioritisation of risks.

The Deputy will also be aware, that an Inter-Departmental/Interagency Group, chaired by my Department, was established to prepare a bid for the relocation of the European Medicines Agency to Dublin. The offer, which can be viewed on , was submitted on 31 July 2017 and a decision is expected at the General Affairs Council on 20 November 2017.

The Department of Health will continue to work closely with the Department of Foreign Affairs and Trade and other Departments on Brexit issues, and to work and contribute as required to the cross-Governmental response, including on the themes identified, in light of the ongoing cross-Government research, analysis and consultations with stakeholders.